BDBM183611 US9145354, 275
SMILES: COc1cc(ccc1C#N)C(=O)c1c(Cl)ccc([C@H](N[C@@H](C)CC(N)=O)C2CC2)c1F
InChI Key: InChIKey=XKZIQGXZLOPEEN-AMXDTQDGSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HCV NS3-NS4A Serine Proteinase (Hepatitis C virus (HCV genotype 1a, isolate H)) | BDBM183611 (US9145354, 275) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 130 | n/a | n/a | n/a | n/a | n/a | 25 |
ASTEX THERAPEUTICS LIMITED US Patent | Assay Description The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ... | US Patent US9145354 (2015) BindingDB Entry DOI: 10.7270/Q2VH5MMZ | |||||||||||
More data for this Ligand-Target Pair |